Physician profile
Gregory Kubicek
NPI 1558427153
$3,677.71
in general payments reported to CMS, 2019-2025
7 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $2,097 · 2021: $329 · 2022: $384 · 2023: $205 · 2024: $261 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $2,953.61 | 2019-2023 | Optune |
| Icotec Medical INC. | $147.13 | 2024 | Icotec Blackarmor Spine System |
| Caris Mpi, INC. | $138.12 | 2025 | Mi Cancer Seek |
| Elekta, INC. | $132.64 | 2023 | Leksell Gamma Knife Icon |
| Merck Sharp & Dohme LLC | $113.63 | 2025 | Keytruda |
| Pfizer INC. | $113.51 | 2024 | |
| Gt Medical Technologies, INC | $79.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kubicek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.